Drug manufacturers are coming up with new versions of their drugs for erectile dysfunction as those drugs’ loss of patent protection and subsequent generic competition draw near, according to published reports.
Healthcare reform has remained a major subject of debate since President Barack Obama signed the Patient Protection and Affordable Care Act last March, but what the law means for diabetes care was the particular focus of a conference call with diabetes stakeholders Tuesday.
In celebration of its newly launched acne-fighting skin care line at Duane Reade, HappyMe Skincare is throwing a bon voyage bash for blemishes during the week of April 11 to 15 at select Duane Reade locations throughout New York.
L'Oréal's Garnier brand has inked an exclusive partnership with TerraCycle, a company specializing in the collection and reuse of nonrecyclable post-consumer waste, to help reduce the amount of personal care and beauty packaging waste sent to landfills. To help support the partnership, a mobile marketing program kicks off in New York on April 11.
A drug originally developed by scientists in the Soviet Union to treat allergies and currently under investigation by Pfizer and Medivation did not yield significant results in a late-stage clinical trial of patients with Huntington disease, a disorder that leads to cognitive decline, the companies said Monday.
Danish drug maker Novo Nordisk has received the Corporate Leadership Award from the National Hemophilia Foundation in response to its research and development efforts for the disease, the company said Friday.
The National Advertising Division of the Council of Better Business Bureaus on Wednesday recommended that DSE Healthcare Solutions, which markets both Cystex urinary pain relief tablets and Cystex liquid cranberry complex with Proantinox, modify its advertising to better distinguish the two products.